Sudeep Pharma
615.10
+1.10(+0.18%)
Market Cap₹6,947.47 Cr
PE Ratio40.87
IndustryHealthcare
Company Performance:
1D+0.18%
1M-3.73%
6M-20.55%
1Y-20.55%
5Y-20.55%
View Company Insightsright
More news about Sudeep Pharma
16Jan 26
Sudeep Pharma Limited Updates CIN and Company Status Following Stock Exchange Listing
Sudeep Pharma Limited has successfully updated its Corporate Identification Number (CIN) from U24231GJ1989PLC013141 to L24231GJ1989PLC013141 on the MCA website following its listing on BSE and NSE on November 28, 2025. The company's status has been changed from unlisted to listed, with the updated master data showing authorized capital of ₹15.00 crores and paid-up capital of ₹11.29 crores. The pharmaceutical company, incorporated in 1989 and based in Gujarat, maintains active compliance status under ROC Ahmedabad jurisdiction.
 no imag found
22Dec 25
Sudeep Pharma Submits Q2FY26 Earnings Call Audio Recording to Stock Exchanges
Sudeep Pharma Limited has completed its Q2FY26 earnings call and submitted the audio recording to stock exchanges in compliance with SEBI regulations. The call was held on December 22, 2025, to discuss performance for the quarter and half-year ended September 30, 2025, with the recording now available on the company's website for stakeholder access.
 no imag found
22Dec 25
Sudeep Pharma Q2 Results: EBITDA Drops 12.6% to ₹55.5 Cr, Margin Shrinks
Sudeep Pharma Limited reported Q2 financial results showing revenue growth of 6.7% to ₹162.80 crores, but faced significant profitability pressures with EBITDA declining 12.6% to ₹55.50 crores and EBITDA margin compressing to 34.09% from 42.66% year-on-year. Net profit also decreased 6.2% to ₹45.70 crores, indicating operational challenges despite top-line growth.
 no imag found
20Dec 25
Sudeep Pharma Completes Q2FY26 Results Publication in Newspapers
Sudeep Pharma Limited completed regulatory compliance by publishing its Q2FY26 financial results extract in newspapers on December 20, 2025. The company reported consolidated revenue of ₹16,266.62 crores and net profit of ₹4,677.82 crores, with detailed results available on stock exchanges and company website.
 no imag found
Sudeep Pharma
615.10
+1.10
(+0.18%)
1 Year Returns:-20.55%
Industry Peers
Sun Pharmaceutical
1,693.60
(-2.02%)
Divis Laboratories
5,856.50
(-0.85%)
Torrent Pharmaceuticals
3,987.20
(-3.02%)
Lupin
2,274.50
(-0.02%)
Dr Reddys Laboratories
1,217.30
(+0.64%)
Cipla
1,192.40
(-0.29%)
Zydus Life Science
864.25
(+0.12%)
Mankind Pharma
1,998.50
(-0.14%)
Aurobindo Pharma
1,333.70
(-0.63%)
Alkem Laboratories
5,258.00
(+0.26%)